Filter Results:
(356)
Show Results For
- All HBS Web
(356)
- People (2)
- News (141)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (72)
Show Results For
- All HBS Web
(356)
- People (2)
- News (141)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (72)
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- 19 May 2009
- First Look
First Look: May 19, 2009
entrepreneurial California agricultural biotech company seeking to earn carbon credits by modifying commodity crops for use in China and India. Eric Rey, Arcadia's CEO, faced a strategic inflection point in early September 2008. The... View Details
Keywords: Martha Lagace
- 15 Dec 2009
- First Look
First Look: Dec. 15, 2009
http://cb.hbsp.harvard.edu/cb/product/510037-PDF-ENG Tengion: Bringing Regenerative Medicine to Life Elie Ofek and Polly Ross RibattHarvard Business School Case 510-031 Tengion is a young biotech company that is at the frontier of... View Details
Keywords: Martha Lagace
- 15 Oct 2013
- First Look
First Look: October 15
science to consumers. It found it increasingly necessary to direct more of its resources towards marketing, including a major investment in Jennifer Aniston as its celebrity spokesperson. Were they becoming less of a biotech company and... View Details
Keywords: Sean Silverthorne
- 15 Sep 2010
- Working Paper Summaries
From Bench to Board: Gender Differences in University Scientists’ Participation in Commercial Science
- Web
Curriculum | MBA
likely in the life sciences or biotech space. Capstone Overview First Year AUGUST Harvard Business School Online CORe Harvard Business School NextGen Biotechnology Harvard Department of Stem Cell and Regenerative Biology FALL TERM Data... View Details
- 15 May 2007
- First Look
First Look: May 15, 2007
Working PapersI'll Have the Ice Cream Soon and the Vegetables Later: Decreasing Impatience over Time in Online Grocery Orders Authors:Todd Rogers, Katherine L. Milkman, and Max H. Bazerman Abstract How do decisions for the near future differ from decisions for the... View Details
Keywords: Martha Lagace
- March 2023
- Case
Moderna
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer, Kerry Herman, Allison J. Wigen and Dave Habeeb
This multimedia case follows the story of Moderna and its entry into vaccine development in the wake of the COVID-19 pandemic. In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19.... View Details
- December 2008 (Revised January 2011)
- Case
Arcadia Biosciences: Seeds of Change
By: Arthur A. Daemmrich, Forest L. Reinhardt and Mary Louise Shelman
Arcadia Biosciences is an entrepreneurial California agricultural biotech company seeking to earn carbon credits by modifying commodity crops for use in China and India. Eric Rey, Arcadia's CEO, faced a strategic inflection point in early September 2008. The company... View Details
Keywords: Business Startups; Entrepreneurship; Growth and Development Strategy; Environmental Sustainability; Science-Based Business; Climate Change; Agriculture and Agribusiness Industry; Biotechnology Industry; China; India; California
Daemmrich, Arthur A., Forest L. Reinhardt, and Mary Louise Shelman. "Arcadia Biosciences: Seeds of Change." Harvard Business School Case 709-019, December 2008. (Revised January 2011.)
- 23 Jul 2020
- News
The Long Game of Coronavirus Research
- October 2001 (Revised March 2002)
- Case
Perlegen Sciences
By: Linda A. Hill and Nicole Tempest
As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained professionals from both the science and technology fields. Perlegen's CEO, Brad Margus,... View Details
Keywords: Innovation Leadership; Groups and Teams; Management Teams; Problems and Challenges; Business Startups; Genetics; Talent and Talent Management; Innovation Strategy; Biotechnology Industry
Hill, Linda A., and Nicole Tempest. "Perlegen Sciences." Harvard Business School Case 402-026, October 2001. (Revised March 2002.)
- February 2022
- Case
Leading The UK Vaccine Task Force
By: Amy C. Edmondson and Claudia Pienica
This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given... View Details
Keywords: COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Financial Services Industry; Public Administration Industry; Europe; United Kingdom
Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
- Web
Faculty & Advisors | MBA
all. Paul Clancy MBA, Columbia University; BS, Babson College Paul has worked in the biotech industry for the last twenty-three years and spent fourteen years in the consumer products industry. He served as the Chief Financial Officer for... View Details
- 22 Apr 2016
- HBS Seminar
Dr. Milt McColl, MD, Gauss Surgical, CEO
- Web
Business & Environment
Times Is Boston Losing Its Biotech Crown? Bio Conference Takes Place Amidst Re: Satish Tadikonda 10 Jun 2025 | Mass Live Measuring Climate Tech Investment Yields a New Shade of 'Green' Business Re: George Serafeim 27 May 2025 | Newsweek... View Details
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
closely with leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of entrepreneurs shaping the future of science. “ Bringing life science innovations to the global... View Details
- Web
Degrees, Certifications & Alumni Status | About
working at the intersection of science and society, with deep understanding of biotechnology, life sciences, and management. The two-year MS/MBA builds upon students’ existing biotech and life sciences knowledge and equips them with the... View Details
- Web
Great American Business Leaders of the 20th Century - Leadership
70 1970 19 Beginning of biotech industry Fiber-optic wire Pong (first video game) UPC bar code Supercomputer Influence: Medium-Low 80 1980 19 Software industry booms PC use expands in scale and scope CAD/CAM revolutionizes manufacturing... View Details
- 30 Mar 2012
- HBS Seminar
Matthew W. Emmens, Executive Chairman,Vertex Pharmaceuticals
- Web
Podcast - Business & Environment
we’re bringing here a bonus episode of Climate Rising. It’s a perfect extension of our two most recent Climate Rising episodes that focus on other low-carbon advanced materials: GALY’s lab-grown cotton and C16 Bioscience’s lab-generated treeless palm oil. A View Details